EDNRA and glaucoma: Researchers have reported lower intraocular pressure in glaucoma animal models after administration of the ETA selective antagonist 97-139 or ETB selective receptor antagonist sarafotoxian S6c and the retinal and choroidal BF were increased in glaucoma patients by taking nonselective receptor antagonist bosentan [11, 12].